NewsRoom Articles - Page 102 of 219

TuesdayOct 11, 2022 1:36 pm

New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths

A new report has highlighted that the rate of death due to cancer in America has steadily declined in the last few decades. As of January 2022, more than 18 million individuals who have survived cancer live in America. This is a new record, especially if one compares the figures against the 3 million survivors recorded in the U.S. in 1971. Researchers predict that by 2040, this number will have reached 24 million. The report, which was released late last month by the American Association for Cancer Research, notes that the number of individuals who survived after receiving their diagnosis…

MondayOct 10, 2022 12:21 pm

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Concussions are a type of brain injury that occurs when the head is struck hard enough that the brain smacks against the skull and is damaged. Such injuries can also happen when the body is shaken violently enough to cause the brain to move around in the skull, such as during whiplash. As with most head injuries, concussions can have major consequences if they are severe or not treated early enough. Over the long term, some patients may develop a condition called post-concussion syndrome, which is characterized by dizziness, headaches and problems with memory and concentration. Aside from car accidents,…

MondayOct 10, 2022 9:00 am

Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol

The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the players According to a report published by Vox, there are approximately 0.41 concussions per NFL game in American football, with 9.3% of concussions involving the loss of consciousness and 2.4% resulting in hospitalizations With such cases, there is a need to revise the NFL’s concussion…

FridayOct 07, 2022 9:26 am

People with Autoimmune Disorders More Likely to Suffer Post-Heart Attack Complications, Study Finds

Autoimmune disorders are conditions that, for some reason, cause the immune system to go haywire and start attacking the body. There are more than 100 autoimmune disorders, with figures showing that at least 50 million individuals in America live with one or more autoimmune disorders. Of this number, an overwhelming majority are women. We still don’t know the exact cause of autoimmune diseases, and scientists still haven’t developed a cure. A recent study sought to understand the association between autoimmune disease and negative outcomes post-heart attack. The research found that people with autoimmune conditions are more likely to have a…

ThursdayOct 06, 2022 10:02 am

New Laws on Abortion May Complicate Cancer Treatment for Pregnant Patients

With abortion bans going into effect in different regions in the country, oncologists are trying to gauge how these new laws will impact treatment options for cancer patients who are pregnant. Cancer coincides with about one in every thousand pregnancies, with cancers such as leukemias, lymphomas, cervical cancer, melanoma and breast cancer being the most common. While the new abortion restrictions stipulate that exceptions based on life-threatening physical conditions and medical emergencies will be permitted, cancer physicians fear misinterpretation, noting that the legal terms remain unclear. Given that most cancer treatments and medications are toxic to growing fetuses and may…

ThursdayOct 06, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Completes Successful Phase I Clinical Trial Showing PRV-002 Concussion Drug Candidate was Safe and Well Tolerated

Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs With concussion representing a high unmet need as there is currently no FDA-approved drug, Odyssey is developing a drug formulation, PRV-002, to be administered to concussed patients; the drug candidate is currently undergoing clinical evaluation In a recent announcement, the company reported the successful completion of its Phase I clinical trial, which showed that the drug was safe and well tolerated Odyssey is looking to present the findings of the Phase I study to the FDA and is also preparing…

WednesdayOct 05, 2022 11:00 am

Study Finds Antibiotics May Boost Melanoma Growth by Depleting Gut Microbiome

New research has found that antibiotics may speed up melanoma growth in bones by weakening the body’s immune response and obstructing microbiome in the gut. Melanoma is an aggressive cancer of the skin that often spreads to a person’s bones. Once this cancer metastasizes, a patient’s five-year rate of survival drops to 30%. Gut microbiome is comprised of trillions of bacteria, fungi and viruses that live within an individual’s intestines. It is estimated that anywhere between 200 to 1,000 bacteria species exist in the gut at any given time. Studies have shown that gut microbiome composition can impact the health…

WednesdayOct 05, 2022 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market

Silo Pharma, Inc recently uplisted to the Nasdaq Capital Market, raising gross proceeds of $5 million The biopharmaceutical company has sought to merge traditional therapeutics and psychedelic research, entering into a series of joint ventures with leading medical universities to carry out research into the field Meanwhile, psychedelics are gaining increasing favour within the United States with Oregon set to begin allowing the supervised usage of psilocybin from 2023 onwards Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced that it had successfully priced its fully underwritten initial public offering,…

TuesdayOct 04, 2022 10:02 am

Frequency of Bowel Movement Could Predict Heart Attack Risk

Heart attacks are medical emergencies that occur when a blood clot hinders blood flow to an individual’s heart. Signs that you may be experiencing a heart attack include shortness of breath, chest pain and pain that travels through your body. A heart attack can be caused by a number of factors, including coronary heart disease. This illness is a major cause of death around the globe and is caused by a build-up of fatty substances in the arterial walls interrupting or blocking the supply of oxygen-rich blood to the heart. While heart disease, which is a heart attack precursor, is…

TuesdayOct 04, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Building on Safety Profile of Concussion Pharmaceutical Treatment, PRV-002, in its Phase I MAD Clinical Trial

Odyssey successfully completed the second Cohort of its Phase I MAD clinical trial, proving the safety profile of its concussion pharmaceutical treatment, PRV-002 This study built on the success of Cohort I, where the drug was well tolerated and proved safe, with no severe adverse events reported The company’s Phase I Single Ascending Dose (“SAD”) cohorts of the clinical trial closed on July 12, 2022, proving the drug was safe and well tolerated. Results from this study were well received by the SRC, who also expressed their optimism for Odyssey’s completion of the MAD portion of its Phase I trial…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol

People with Autoimmune Disorders More Likely to Suffer Post-Heart Attack Complications, Study Finds

New Laws on Abortion May Complicate Cancer Treatment for Pregnant Patients

Odyssey Health, Inc. (ODYY) Completes Successful Phase I Clinical Trial Showing PRV-002 Concussion Drug Candidate was Safe and Well Tolerated

Study Finds Antibiotics May Boost Melanoma Growth by Depleting Gut Microbiome

Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market

Frequency of Bowel Movement Could Predict Heart Attack Risk

Odyssey Health, Inc. (ODYY) Building on Safety Profile of Concussion Pharmaceutical Treatment, PRV-002, in its Phase I MAD Clinical Trial

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search